|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.18 USD | -0.92% |
|
-0.60% | +2.77% |
| Capitalization | 269B 228B 212B 198B 369B 24,669B 391B 2,419B 960B 11,648B 1,007B 986B 42,369B | P/E ratio 2025 * |
13.9x | P/E ratio 2026 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise value | 293B 249B 231B 216B 402B 26,927B 427B 2,641B 1,048B 12,714B 1,099B 1,077B 46,248B | EV / Sales 2025 * |
4.52x | EV / Sales 2026 * | 4.23x |
| Free-Float |
70.67% | Yield 2025 * |
2.99% | Yield 2026 * | 3.01% |
Last Transcript: Merck & Co., Inc.
| 1 day | -0.92% | ||
| 1 week | -0.60% | ||
| Current month | +2.77% | ||
| 1 month | +2.99% | ||
| 3 months | +24.09% | ||
| 6 months | +28.82% | ||
| Current year | +2.77% |
| 1 week | 106.93 |  | 111.97 |
| 1 month | 104.43 | | 112.9 |
| Current year | 104.43 | | 112.9 |
| 1 year | 73.31 | | 112.9 |
| 3 years | 73.31 | | 134.63 |
| 5 years | 70.89 | | 134.63 |
| 10 years | 47.97 | | 134.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 59 | 01/07/2021 |
| Director of Finance/CFO | 57 | 01/04/2021 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 65 | 27/11/2007 |
Patricia Russo
BRD | Director/Board Member | 73 | 01/09/1995 |
Robert Davis
CHM | Chairman | 59 | 01/12/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.29% | 14.34% | 253 M€ | |
| +0.75% | 5.61% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.92% | -0.60% | +11.95% | -1.55% | 269B | |
| -2.12% | +2.49% | +38.83% | +211.00% | 953B | |
| +0.76% | +0.68% | +50.12% | +30.79% | 530B | |
| +0.53% | +2.29% | +28.47% | +47.60% | 388B | |
| +0.06% | -0.23% | +26.86% | +17.82% | 377B | |
| +0.15% | -3.36% | +22.94% | +23.03% | 286B | |
| +0.47% | +0.03% | +28.12% | +35.36% | 281B | |
| +1.17% | +3.20% | -30.92% | -16.86% | 281B | |
| -0.67% | +4.34% | +24.06% | +32.10% | 186B | |
| +3.65% | +8.82% | +46.29% | +63.32% | 169B | |
| Average | +0.31% | +1.55% | +24.67% | +44.26% | 371.91B | |
| Weighted average by Cap. | -0.17% | +1.27% | +28.51% | +72.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 64.79B 55.1B 51.08B 47.73B 88.98B 5,953B 94.31B 584B 232B 2,811B 243B 238B 10,224B | 67.68B 57.56B 53.35B 49.86B 92.94B 6,218B 98.51B 610B 242B 2,936B 254B 249B 10,679B |
| Net income | 20.08B 17.08B 15.83B 14.8B 27.58B 1,845B 29.23B 181B 71.84B 871B 75.31B 73.77B 3,169B | 14.48B 12.31B 11.41B 10.66B 19.88B 1,330B 21.07B 130B 51.78B 628B 54.28B 53.17B 2,284B |
| Net Debt | 24.58B 20.91B 19.38B 18.11B 33.76B 2,258B 35.78B 221B 87.92B 1,066B 92.17B 90.28B 3,879B | 17.89B 15.21B 14.1B 13.18B 24.57B 1,644B 26.04B 161B 63.98B 776B 67.08B 65.7B 2,823B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 108.18 $ | -0.92% | 10,489,492 |
| 22/01/26 | 109.18 $ | -1.74% | 9,362,585 |
| 21/01/26 | 111.11 $ | +1.52% | 12,844,383 |
| 20/01/26 | 109.45 $ | +0.57% | 15,241,138 |
| 16/01/26 | 108.83 $ | -1.93% | 14,852,069 |
Delayed Quote Nyse, 24 January 2026 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition